多发性骨髓瘤BCMA CAR-T治疗后神经毒性相关脑FDG-PET改变
这项回顾性探索性研究纳入20例接受BCMA CAR-T细胞治疗的多发性骨髓瘤患者(其中15例有基线PET),用18F-FDG-PET评估脑代谢与代谢连接。7例发生神经毒性,其治疗后左中央前回和纹状体FDG摄取显著降低,且左枕下皮层和纹状体摄取下降幅度大于无神经毒性者;代谢连接分析显示508个区域对显著改变,以额颞相关减低为主。
要点
- BCMA CAR-T后神经毒性患者左中央前回和纹状体FDG摄取显著降低。
- 神经毒性者左枕下皮层和纹状体FDG摄取下降幅度大于无神经毒性者。
- 代谢连接以额颞相关减低为主,网络中心性向颞枕区重分布。
核心结论
- BCMA CAR-T治疗后发生神经毒性的患者,在18F-FDG-PET上表现出代谢水平和网络水平的 distinct 差异。
- 脑PET成像有潜力阐明神经毒性的潜在机制,值得在更大队列中进一步研究。
研究设计与样本
- 回顾性探索性研究,纳入20例接受BCMA CAR-T细胞治疗的多发性骨髓瘤患者,其中15例有基线脑18F-FDG-PET。
- 以小脑为参考区计算标准化摄取值比(SUVR)量化脑代谢,并用相关矩阵和网络拓扑指标评估代谢连接。
- 代谢模式经年龄校正后,比较有神经毒性与无神经毒性患者。
主要发现
- 7例患者发生神经毒性。
- 涉及神经毒性患者的SUVR分析显示,治疗后左中央前回和纹状体FDG摄取显著降低。
- 与无神经毒性患者相比,神经毒性患者左枕下皮层和纹状体FDG摄取下降幅度更大。
- 代谢连接分析识别出508个显著改变的区域对,主要以额颞相关减低为主。
- 枢纽节点分析显示网络中心性从高级皮层区域向颞区和枕区重分布,神经毒性患者岛叶和边缘区中心性降低。
临床怎么用
- 对于BCMA CAR-T治疗后出现神经毒性的多发性骨髓瘤患者,可考虑用脑18F-FDG-PET评估代谢改变。
- 判读时可关注左中央前回、纹状体、左枕下皮层FDG摄取及额颞代谢连接改变。
- 目前证据为探索性,脑PET发现需结合临床,尚不能作为常规决策依据。
局限性
- 回顾性探索性研究,样本量小(20例,仅15例有基线PET),结论需更大队列验证。
- 原文未报告神经毒性的具体分级标准、PET扫描时间窗及统计校正细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This exploratory study investigated alterations in cerebral metabolism and metabolic connectivity using 18 F-fluorodeoxyglucose positron emission tomography (F-18 FDG-PET) in patients with multiple myeloma with neurotoxicity after B-cell maturation antigen (BCMA)-directed chimeric antigen receptor (CAR) T-cell therapy. PATIENTS AND METHODS: The retrospective study included 20 BCMA CAR T-cell therapy recipients who underwent brain F-18 FDG-PET imaging (15 with baseline PET scans). Brain metabolism was quantified using standardized uptake value ratios (SUVRs), with the cerebellum as the reference region. Metabolic connectivity was assessed using correlation matrices and network topology metrics. Metabolic patterns were age-adjusted and compared between patients with and without neurotoxicity. RESULTS: Neurotoxicity occurred in 7 patients. SUVR analysis involving those with neurotoxicity demonstrated significantly reduced post-treatment FDG uptake in the left precentral gyrus and striatum. Greater declines were observed in FDG uptake within the left inferior occipital cortex and striatum in patients with neurotoxicity than in those without. Metabolic connectivity analysis identified 508 significantly altered regional pairs, primarily with reduced frontotemporal correlations. Hub node analysis demonstrated a redistribution of network centrality from higher-order cortical regions to temporal and occipital areas, with reduced centrality in the insular and limbic regions among patients with neurotoxicity. CONCLUSIONS: Patients with neurotoxicity after BCMA CAR T-cell therapy demonstrated distinct metabolic-level and network-level differences on F-18 FDG-PET, highlighting the potential of brain PET imaging to elucidate the underlying mechanisms and warranting further investigation in larger cohorts.
引用
- Ko KY, Zhmakin V, Wang DS, et al. Neurotoxicity-Associated Brain FDG-PET Alterations Following BCMA CAR T-Cell Therapy in Multiple Myeloma. Clin Nucl Med. 2026. PMID: 42080607. doi:10.1097/RLU.0000000000006496
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。